Evidence map›Paper›PMID 33306104›Full record

ArticleEuropean heart journal. Cardiovascular Imaging2021

Prevalence and clinical implications of valvular calcification on coronary computed tomography angiography.

Michelle C Williams, Daniele Massera, Alastair J Moss, Rong Bing, Anda Bularga, Philip D Adamson, Amanda Hunter, Shirjel Alam, Anoop S V Shah, Tania Pawade and 5 more

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in European heart journal. Cardiovascular Imaging, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06660524 (Clinical Study on the Influence of Calcium and Phosphorus Regulation Therapy on Valvular Heart Disease.), which is not on this map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06660524 phase4recruitingnot on this mapstarted 2024, after this paper: background citation

Clinical Study on the Influence of Calcium and Phosphorus Regulation Therapy on Valvular Heart Disease.

TypeinterventionalSponsorChina National Center for Cardiovascular DiseasesRan2024 to 2025Enrolled196ConditionsDegenerative Heart Valve Disease, Heart Valve Calcification, Chronic Kidney Disease(CKD), Calcium-Phosphorus Metabolism DisordersArmsSevelamer, Calcium carbonate
3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 30 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Nomograms Based on the Advanced Lung Cancer Inflammation Index for the Prediction of Coronary Artery Disease and Calcification.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 3 countries.

Michelle C WilliamsUniversity of Edinburgh/British Heart Foundation Centre for Cardiovascular Science, Chancellor's Building, 49 Little France Crescent, Edinburgh EH164SB, UK.
Daniele MasseraMontefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY 10461, USA.
Alastair J MossUniversity of Edinburgh/British Heart Foundation Centre for Cardiovascular Science, Chancellor's Building, 49 Little France Crescent, Edinburgh EH164SB, UK.
Rong BingUniversity of Edinburgh/British Heart Foundation Centre for Cardiovascular Science, Chancellor's Building, 49 Little France Crescent, Edinburgh EH164SB, UK.
Anda BulargaUniversity of Edinburgh/British Heart Foundation Centre for Cardiovascular Science, Chancellor's Building, 49 Little France Crescent, Edinburgh EH164SB, UK.
Philip D AdamsonUniversity of Edinburgh/British Heart Foundation Centre for Cardiovascular Science, Chancellor's Building, 49 Little France Crescent, Edinburgh EH164SB, UK.
Amanda HunterUniversity of Edinburgh/British Heart Foundation Centre for Cardiovascular Science, Chancellor's Building, 49 Little France Crescent, Edinburgh EH164SB, UK.
Shirjel AlamUniversity of Edinburgh/British Heart Foundation Centre for Cardiovascular Science, Chancellor's Building, 49 Little France Crescent, Edinburgh EH164SB, UK.
Anoop S V ShahUniversity of Edinburgh/British Heart Foundation Centre for Cardiovascular Science, Chancellor's Building, 49 Little France Crescent, Edinburgh EH164SB, UK.
Tania PawadeUniversity of Edinburgh/British Heart Foundation Centre for Cardiovascular Science, Chancellor's Building, 49 Little France Crescent, Edinburgh EH164SB, UK.
Giles RoditiGlasgow Clinical Research Imaging Facility, Queen Elizabeth University Hospital, Glasgow G514LB, UK.
Edwin J R van BeekEdinburgh Imaging Facility QMRI, University of Edinburgh, Edinburgh EH164TJ, UK.
Edward D Nicol
David E NewbyUniversity of Edinburgh/British Heart Foundation Centre for Cardiovascular Science, Chancellor's Building, 49 Little France Crescent, Edinburgh EH164SB, UK.
Marc R DweckUniversity of Edinburgh/British Heart Foundation Centre for Cardiovascular Science, Chancellor's Building, 49 Little France Crescent, Edinburgh EH164SB, UK.
British Heart Foundation · GBAlbert Einstein College of Medicine · USQueen Elizabeth University Hospital · GBUniversity of Edinburgh · GB

Funding

British Heart Foundation CH/09/002/26360British Heart Foundation FS/14/78/31020British Heart Foundation FS/16/19/31982British Heart Foundation PG/19/40/34422British Heart Foundation RG/16/10/32375Medical Research Council G0701127Wellcome Trust
6 · The paper itself

Abstract

aimsValvular heart disease can be identified by calcification on coronary computed tomography angiography (CCTA) and has been associated with adverse clinical outcomes. We assessed aortic and mitral valve calcification in patients presenting with stable chest pain and their association with cardiovascular risk factors, coronary artery disease, and cardiovascular outcomes. METHODS AND

resultsIn 1769 patients (58 ± 9 years, 56% male) undergoing CCTA for stable chest pain, aortic and mitral valve calcification were quantified using Agatston score. Aortic valve calcification was present in 241 (14%) and mitral calcification in 64 (4%). Independent predictors of aortic valve calcification were age, male sex, hypertension, diabetes mellitus, and cerebrovascular disease, whereas the only predictor of mitral valve calcification was age. Patients with aortic and mitral valve calcification had higher coronary artery calcium scores and more obstructive coronary artery disease. The composite endpoint of cardiovascular mortality, non-fatal myocardial infarction, or non-fatal stroke was higher in those with aortic [hazard ratio (HR) 2.87; 95% confidence interval (CI) 1.60-5.17; P < 0.001] or mitral (HR 3.50; 95% CI 1.47-8.07; P = 0.004) valve calcification, but this was not independent of coronary artery calcification or obstructive coronary artery disease.

conclusionAortic and mitral valve calcification occurs in one in six patients with stable chest pain undergoing CCTA and is associated with concomitant coronary atherosclerosis. Whilst valvular calcification is associated with a higher risk of cardiovascular events, this was not independent of the burden of coronary artery disease.

Indexed as

CalcinosisCoronary Artery DiseaseAortic ValveComputed Tomography AngiographyCoronary AngiographyFemaleHumansMalePrevalenceRisk Factorsaortic valvecomputed tomographycomputed tomography coronary angiographymitral valve

Identifiers

PMID33306104
PMCPMC7899264
OpenAlexW3111182104

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.